Lv3
398 积分 2024-12-31 加入
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
1年前
已完结
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
1年前
已完结
Pneumocystis pneumonia after lung transplantation: A retrospective multicenter study
1年前
已完结
Efficacy of Ceftriaxone or Meropenem as Initial Therapies in Whipple's Disease
1年前
已关闭
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
1年前
已完结
A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study
1年前
已完结
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species
1年前
已完结
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review
1年前
已完结
Linezolid as salvage therapy for central nervous system infections due to methicillin-resistant Staphylococcus aureus at two medical centers in Taiwan
1年前
已关闭
Macrolides versus other antibiotics in pediatric scrub typhus: A meta-analysis
1年前
已关闭
皖公网安备34019202002308
